|SEQ_NO||1||Date of announcement||2020/03/12||Time of announcement||14:05:47|
|Subject||Announcement of TTY Biopharm's unaudited income information in Feb 2020|
|Date of events||2020/3/12||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/03/12
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $315,671 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $56,833 thousands, and a consolidated income before tax of $66,363 thousands in Feb 2020; net income attributed to stockholders of the company was $51,935 thousands; EPS is $0.21.
Year-to-date consolidated net sales was $685,764 thousands (in NT dollars; unaudited), a consolidated operating profit was $163,195 thousands and consolidated income before tax was $190,336 thousands until Feb 2020; year-to-date net income attributed to stockholders of the company was $148,173 thousands; EPS is $0.60.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.